APLT

Applied Therapeutics, Inc.

7.06 USD
-0.01 (-0.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Applied Therapeutics, Inc. stock is up 133.77% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 3 PUTs, 7 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
28 Feb 18:02 15 Mar, 2024 7.50 PUT 887 2
28 Feb 18:02 15 Mar, 2024 7.50 PUT 888 2
28 Feb 18:03 15 Mar, 2024 7.50 PUT 827 2
28 Feb 18:32 19 Apr, 2024 7.50 CALL 200 2034
28 Feb 20:05 19 Apr, 2024 7.50 CALL 266 2034
28 Feb 20:05 19 Apr, 2024 7.50 CALL 547 2034
29 Feb 15:29 19 Apr, 2024 7.50 CALL 969 2728
29 Feb 18:48 19 Apr, 2024 7.50 CALL 500 2728
29 Feb 19:00 19 Apr, 2024 7.50 CALL 403 2728
29 Feb 20:52 19 Jul, 2024 5.00 CALL 100 1564

About Applied Therapeutics, Inc.

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosmia in healthy volunteers and adults. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for treatment of diabetic peripheral neuropathy.

  • Leerink Partners
    Thu Feb 22, 07:38
    buy
    initial
  • Citigroup
    Fri Feb 16, 12:06
    buy
    confirm